Editor in Chief & Acting CEO update: 14 May 2021

picture of connections between social avatars

Dear Cochrane friends and colleagues,

I hope this message finds you well, despite the continued challenges facing many of us all over the world.

Organizational and editorial updates

  • Governance Meetings: We announced in late April that our 2021 Governance Meetings will be divided into two parts: (1) a series of business meetings to be held in May Group Executives, all Co-ordinating Editors, members of the Author Form, members of the Early Career Professionals Network, and the Cochrane Council; and (2) strategic and discussion sessions on 22 and 24 June for all members and supporters, covering topics including the Editorial Independence & Efficiency project and outcomes from the business meetings. Registration for June’s Governance Meetings will open soon and details will be shared in my next update and on the Cochrane Community Governance Meetings page.
  • Editorial Independence and Efficiency Project: We are pleased to announce that the Project Advisory Group and Central Editorial Service Working Groups have been formed. You can see a list of group members and find out more about the role of these Groups, plus other project details on the website: https://community.cochrane.org/eiep.
    The first five CRGs to join the pilot project have also been confirmed, and are:
    • Cochrane Colorectal
    • Cochrane Haematology
    • Cochrane Injuries
    • Cochrane Multiple Sclerosis and Rare Diseases of the CNS
    • Cochrane Neonatal
  • Join the Conversation: Recordings from last week’s webinar have now been posted; watch the recordings or sign up for future webinars.
  • Clinical Trial Transparency: Cochrane has shown our support for the WHO-ICMRA statement on transparency and data integrity and has signed a letter requesting medicines regulators in Europe address unpublished clinical trials.
  • WHO request for proposals: The WHO has published a request for proposals to draft and finalize the WHO handbook for the development and quality assurance of normative and standard-setting products. Learn more and apply by May 21. 

COVID-19 response

With best wishes,

Karla Soares-Weiser (MD, MSc, PhD)
Acting CEO
Editor in Chief, Cochrane Library
Editorial & Methods Department | Cochrane Central Executive

May 14, 2021
Share